Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
Hematologic Oncology Update
The Potential of Checkpoint Inhibitors in AML and MDS
The speakers discuss the current limitations of checkpoint inhibitors in treating AML and MDS and highlight the potential of targeting the innate immune system for better outcomes. Ongoing studies and clinical trials in this area are also discussed.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
